𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Clinical usefulness of des-γ-carboxy prothrombin assay in early diagnosis of hepatocellular carcinoma

✍ Scribed by Shigetoshi Fujiyama; Kiyonori Izuno; Kazuto Gohshi; Junji Shibata; Tatsuo Sato

Book ID
112509240
Publisher
Springer US
Year
1991
Tongue
English
Weight
534 KB
Volume
36
Category
Article
ISSN
0163-2116

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The usefulness of determining des-γ-carb
The usefulness of determining des-γ-carboxy prothrombin by sensitive enzyme immunoassay in the early diagnosis of patients with hepatocellular carcinoma
✍ Yuhsaku Mita; Yutaka Aoyagi; Masahiko Yanagi; Takeshi Suda; Yasufumi Suzuki; Hit 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB 👁 1 views

## Background: Measurements of serum concentrations of des-gamma-carboxy prothrombin (dcp) are widely used for diagnosing hepatocellular carcinoma (hcc). however, the dcp is not always sensitive enough to detect small hccs. in the current study, the authors investigated the usefulness of dcp in the

Usefulness of simultaneous determination
Usefulness of simultaneous determination of α-fetoprotein and des-γ-carboxy prothrombin in hepatocellular carcinoma
✍ Akimasa Nakao; Kenji Taniguchi; Soichiro Inoue; Akio Harada; Toshiaki Nonami; Ke 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 323 KB

Serum y-fetoprotein (AFP) and plasma des-y-carboxy prothrombin (DCP), a protein induced by vitamin K absence or antagonist I1 (PIVKA-11) levels, were measured in 197 patients with primary hepatocellular carcinoma (HCC). DCP levels were determined by conventional enzyme immunoassay kit (E-1023) and a

Plasma abnormal prothrombin (Des-γ-carbo
Plasma abnormal prothrombin (Des-γ-carboxy prothrombin) as a marker of hepatocellular carcinoma
✍ Shigetoshi Fujiyama; Takafumi Morishita; Osamu Hashiguchi; Tatsuo Sato 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 732 KB

Des-y-carboxy prothrombin [DCP], a protein induced by vitamin K absence or antagonist-I1 and also abbreviated PIVKA-11, was evaluated as a serologic marker for hepatocellular carcinoma (HCC). Its plasma levels were measured by enzyme immunoassay (E-1023) using an anti-DCP monoclonal antibody in 514